Inventor · disambiguated record
Timothy Pietro Suren Perera
Also filed as: PERERA TIMOTHY PIETRO SUREN
22 granted patents·7 pending applications·145 citations·filing 2004–2021
95Inventor score
Files withJANSSEN PHARMACEUTICA NV13ASTEX THERAPEUTICS LTD9FREYNE EDDY JEAN EDGARD5PERERA TIMOTHY PIETRO SUREN1SAXTY GORDON1
Top patents by PatentIndex Score
29 records- 0195US9850228B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Dec 26, 2017·17 cites·5 claims
- 0295US9464071B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Oct 11, 2016·24 cites·45 claims
- 0394US8895601B2Pyrazolyl quinoxaline kinase inhibitorsSAXTY GORDON·Filed 2011·Granted Nov 25, 2014·25 cites·36 claims
- 0490US10519137B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2017·Granted Dec 31, 2019·6 cites·18 claims
- 0590US10085982B2CombinationsASTEX THERAPEUTICS LTD·Filed 2015·Granted Oct 2, 2018·12 cites·12 claims
- 0688US10716787B2CombinationsASTEX THERAPEUTICS LTD·Filed 2018·Granted Jul 21, 2020·3 cites·13 claims
- 0787US10736900B2Combinations of an FGFR inhibitor and an IGF1R inhibitorASTEX THERAPEUTICS LTD·Filed 2015·Granted Aug 11, 2020·4 cites·7 claims
- 0885US7655642B23-cyano-quinoline derivatives with antiproliferative activityJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Feb 2, 2010·13 cites·5 claims
- 0984US7799772B2Pyrido-and pyrimidopyrimidine derivatives as anti-profilerative agentsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Sep 21, 2010·16 cites·6 claims
- 1083US8394786B2Quinazoline derivativesFREYNE EDDY JEAN EDGARD·Filed 2009·Granted Mar 12, 2013·5 cites·8 claims
- 1182US7648975B2Macrocyclic quinazoline derivatives as antiproliferative agentsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Jan 19, 2010·12 cites·8 claims
- 1278US7947695B25-membered annelated heterocyclic pyrimidines as kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted May 24, 2011·4 cites·19 claims
- 1377US2022135544A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1474US10138246B2Deuterated triazolopyridazine as a kinase modulatorJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Nov 27, 2018·2 cites·17 claims
- 1573US7947694B2Substituted pyrazolo[3,4-D]pyrimidines as cell cycle kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted May 24, 2011·2 cites·16 claims
- 1668US2020131153A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 1767US9365517B23-cyano-quinoline derivatives with antiproliferative activityJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 14, 2016·0 cites·1 claims
- 1867US8778920B23-cyano-quinoline derivatives with antiproliferative activityFREYNE EDDY JEAN EDGARD·Filed 2009·Granted Jul 15, 2014·0 cites·6 claims
- 1966US11918576B2Combination of an FGFR inhibitor and a CMET inhibitorASTEX THERAPEUTICS LTD·Filed 2020·Granted Mar 5, 2024·0 cites·19 claims
- 2064US9040511B23-cyano-quinoline derivatives with antiproliferative activityJANSSEN PHARMACEUTICA NV·Filed 2013·Granted May 26, 2015·0 cites·4 claims
- 2159US8933067B2Pyrido and pyrimidopyrimidine derivatives as anti-profilerative agentsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jan 13, 2015·0 cites·8 claims
- 2258US9273013B2Quinazoline derivativesJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Mar 1, 2016·0 cites·1 claims
- 2357US2008213275A1Use of mtki 1 for treating or preventing bone cancerFREYNE EDDY JEAN EDGARD·Filed 2007·Application pending·0 cites
- 2455US10464939B2Deuterated triazolopyridazine as a kinase modulatorJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Nov 5, 2019·0 cites·2 claims
- 2553US2016207938A1Quinazoline derivativesJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 2651US8772272B2Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agentsFREYNE EDDY JEAN EDGARD·Filed 2010·Granted Jul 8, 2014·0 cites·3 claims
- 2746US2008153853A1Use of mtki 1 for treating or preventing brain cancerFREYNE EDDY JEAN EDGARD·Filed 2007·Application pending·0 cites
- 2844US2010234238A1Method for profiling kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Application pending·0 cites
- 2943US2008219975A1Vegfr3 inhibitorsPERERA TIMOTHY PIETRO SUREN·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →